{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:05:03Z","timestamp":1790910303876,"version":"4.1.0"},"reference-count":53,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2017,10,23]],"date-time":"2017-10-23T00:00:00Z","timestamp":1508716800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0186305","type":"journal-article","created":{"date-parts":[[2017,10,23]],"date-time":"2017-10-23T18:01:32Z","timestamp":1508781692000},"page":"e0186305","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":30,"title":["Use of immunohistochemical biomarkers as independent predictor of neoplastic progression in Barrett's oesophagus surveillance: A systematic review and meta-analysis"],"prefix":"10.1371","volume":"12","author":[{"given":"Vincent T.","family":"Janmaat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie H.","family":"van Olphen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina E.","family":"Biermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leendert H. J.","family":"Looijenga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco B.","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9103-9757","authenticated-orcid":true,"given":"Manon C. W.","family":"Spaander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,10,23]]},"reference":[{"issue":"3","key":"ref1","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1053\/j.gastro.2011.01.031","article-title":"American Gastroenterological Association medical position statement on the management of Barrett's esophagus","volume":"140","author":"SJ Spechler","year":"2011","journal-title":"Gastroenterology"},{"issue":"5","key":"ref2","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1159\/000331513","article-title":"Role of acid suppression in the development and progression of dysplasia in patients with Barrett's esophagus","volume":"29","author":"F Kastelein","year":"2011","journal-title":"Digestive diseases"},{"issue":"1","key":"ref3","first-page":"118","article-title":"Barrett's esophagus. A prevalent, occult complication of gastroesophageal reflux disease","volume":"92","author":"C Winters Jr.","year":"1987","journal-title":"Gastroenterology"},{"issue":"2","key":"ref4","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ncpgasthep0057","article-title":"Mechanisms of disease: Carcinogenesis in Barrett's esophagus","volume":"1","author":"NS Buttar","year":"2004","journal-title":"Nature clinical practice Gastroenterology & hepatology"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1136\/gutjnl-2013-305372","article-title":"British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus","volume":"63","author":"RC Fitzgerald","year":"2014","journal-title":"Gut"},{"issue":"3","key":"ref6","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/j.1572-0241.2008.01835.x","article-title":"Practice Parameters Committee of the American College of G. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus","volume":"103","author":"KK Wang","year":"2008","journal-title":"The American journal of gastroenterology"},{"issue":"6","key":"ref7","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1038\/ajg.2009.159","article-title":"Receipt of previous diagnoses and endoscopy and outcome from esophageal adenocarcinoma: a population-based study with temporal trends","volume":"104","author":"GS Cooper","year":"2009","journal-title":"The American journal of gastroenterology"},{"issue":"8","key":"ref8","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1002\/bjs.4591","article-title":"Effect of surveillance of Barrett's oesophagus on the clinical outcome of oesophageal cancer","volume":"91","author":"A Fountoulakis","year":"2004","journal-title":"The British journal of surgery"},{"key":"ref9","article-title":"Impact of surveillance for Barrett's oesophagus on tumour stage and survival of patients with neoplastic progression","author":"F Kastelein","year":"2015","journal-title":"Gut"},{"issue":"5","key":"ref10","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.gie.2008.02.062","article-title":"Effect of a prior endoscopy on outcomes of esophageal adenocarcinoma among United States veterans","volume":"68","author":"JH Rubenstein","year":"2008","journal-title":"Gastrointestinal endoscopy"},{"issue":"7","key":"ref11","first-page":"1669","article-title":"Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets","volume":"95","author":"BJ Reid","year":"2000","journal-title":"The American journal of gastroenterology"},{"issue":"3","key":"ref12","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.cgh.2009.10.010","article-title":"Risk of esophageal adenocarcinoma and mortality in patients with Barrett's esophagus: a systematic review and meta-analysis","volume":"8","author":"M Sikkema","year":"2010","journal-title":"Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association"},{"issue":"3","key":"ref13","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/aje\/kwn121","article-title":"The incidence of esophageal cancer and high-grade dysplasia in Barrett's esophagus: a systematic review and meta-analysis","volume":"168","author":"F Yousef","year":"2008","journal-title":"American journal of epidemiology"},{"issue":"12","key":"ref14","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1080\/00365520410003524","article-title":"Oesophageal cancer incidence and mortality in patients with long-segment Barrett's oesophagus after a mean follow-up of 12.7 years","volume":"39","author":"M Hage","year":"2004","journal-title":"Scandinavian journal of gastroenterology"},{"issue":"13","key":"ref15","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/jnci\/djr203","article-title":"Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study","volume":"103","author":"S Bhat","year":"2011","journal-title":"Journal of the National Cancer Institute"},{"issue":"7","key":"ref16","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1136\/gutjnl-2011-300730","article-title":"The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett's oesophagus: a meta-analysis","volume":"61","author":"TK Desai","year":"2012","journal-title":"Gut"},{"issue":"7","key":"ref17","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1038\/ajg.2011.145","article-title":"The incidence of esophageal adenocarcinoma in Barrett's esophagus has been overestimated","volume":"106","author":"TK Desai","year":"2011","journal-title":"The American journal of gastroenterology"},{"issue":"15","key":"ref18","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1056\/NEJMoa1103042","article-title":"Incidence of adenocarcinoma among patients with Barrett's esophagus","volume":"365","author":"F Hvid-Jensen","year":"2011","journal-title":"The New England journal of medicine"},{"issue":"3","key":"ref19","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.cgh.2010.11.008","article-title":"Patients with nondysplastic Barrett's esophagus have low risks for developing dysplasia or esophageal adenocarcinoma","volume":"9","author":"S Wani","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"ref20","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1053\/j.gastro.2011.10.034","article-title":"Tobacco smoking increases the risk of high-grade dysplasia and cancer among patients with Barrett's esophagus","volume":"142","author":"HG Coleman","year":"2012","journal-title":"Gastroenterology"},{"issue":"7","key":"ref21","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/ajg.2010.171","article-title":"Low-grade dysplasia in Barrett's esophagus: overdiagnosed and underestimated","volume":"105","author":"WL Curvers","year":"2010","journal-title":"The American journal of gastroenterology"},{"issue":"7","key":"ref22","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/j.1365-2559.2007.02706.x","article-title":"Grading of dysplasia in Barrett's oesophagus: substantial interobserver variation between general and gastrointestinal pathologists","volume":"50","author":"M Kerkhof","year":"2007","journal-title":"Histopathology"},{"issue":"4","key":"ref23","first-page":"586","article-title":"Barrett's esophagus, high-grade dysplasia, and early adenocarcinoma: a pathological study","volume":"92","author":"AJ Cameron","year":"1997","journal-title":"The American journal of gastroenterology"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/0016-5085(93)90008-Z","article-title":"An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus","volume":"105","author":"DS Levine","year":"1993","journal-title":"Gastroenterology"},{"issue":"10","key":"ref25","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"62","author":"D Moher","year":"2009","journal-title":"J Clin Epidemiol"},{"issue":"15","key":"ref26","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group","volume":"283","author":"DF Stroup","year":"2000","journal-title":"Jama"},{"issue":"No. 2","key":"ref27","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3102\/1076998609346961","article-title":"How Many Studies Do You Need? A Primer on Statistical Power for Meta-Analysis","volume":"Vol. 35","author":"JC Valentine","year":"2010","journal-title":"Journal of Educational and Behavioral Statistics"},{"issue":"4","key":"ref28","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1023\/A:1018828207371","article-title":"p53 Protein accumulation is a specific marker of malignant potential in Barrett's metaplasia","volume":"42","author":"M Younes","year":"1997","journal-title":"Digestive diseases and sciences"},{"issue":"16","key":"ref29","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1093\/jnci\/92.16.1316","article-title":"Prospective study of cyclin D1 overexpression in Barrett's esophagus: association with increased risk of adenocarcinoma","volume":"92","author":"K Bani-Hani","year":"2000","journal-title":"Journal of the National Cancer Institute"},{"issue":"5","key":"ref30","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1111\/j.1572-0241.2001.03851.x","article-title":"p53 protein overexpression in low grade dysplasia (LGD) in Barrett's esophagus: immunohistochemical marker predictive of progression","volume":"96","author":"AP Weston","year":"2001","journal-title":"The American journal of gastroenterology"},{"issue":"10","key":"ref31","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1111\/j.1572-0241.2002.06032.x","article-title":"p53 expression in low grade dysplasia in Barrett's esophagus: correlation with interobserver agreement and disease progression","volume":"97","author":"M Skacel","year":"2002","journal-title":"The American journal of gastroenterology"},{"issue":"10","key":"ref32","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1136\/gut.2005.083295","article-title":"TP53 and progression from Barrett's metaplasia to oesophageal adenocarcinoma in a UK population cohort","volume":"55","author":"L Murray","year":"2006","journal-title":"Gut"},{"issue":"11","key":"ref33","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1038\/ajg.2009.437","article-title":"Aneuploidy and overexpression of Ki67 and p53 as markers for neoplastic progression in Barrett's esophagus: a case-control study","volume":"104","author":"M Sikkema","year":"2009","journal-title":"The American journal of gastroenterology"},{"issue":"4","key":"ref34","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1053\/j.gastro.2012.06.041","article-title":"Population-based study reveals new risk-stratification biomarker panel for Barrett's esophagus","volume":"143","author":"EL Bird-Lieberman","year":"2012","journal-title":"Gastroenterology"},{"issue":"12","key":"ref35","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1136\/gutjnl-2012-303594","article-title":"Aberrant p53 protein expression is associated with an increased risk of neoplastic progression in patients with Barrett's oesophagus","volume":"62","author":"F Kastelein","year":"2013","journal-title":"Gut"},{"key":"ref36","unstructured":"Davelaar AL, Calpe S Fau\u2014Lau L, Lau L Fau\u2014Timmer MR, Timmer Mr Fau\u2014Visser M, Visser M Fau\u2014Ten Kate FJ, Ten Kate Fj Fau\u2014Parikh KB, et al. Aberrant TP53 detected by combining immunohistochemistry and DNA-FISH improves Barrett's esophagus progression prediction: a prospective follow-up study. (1098\u20132264 (Electronic))."},{"issue":"12","key":"ref37","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.5858\/1999-123-1260-IDOPPC","article-title":"Immunohistochemical detection of p53 protein could improve the management of some patients with Barrett esophagus and mild histologic alterations","volume":"123","author":"A Gimenez","year":"1999","journal-title":"Arch Pathol Lab Med"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Brown K, Younes M, Ertan A, Verm R, Meriano FV. M1928 P53 Immunostaining Predicts Malignant Progression in Barrett's Metaplasia: WB Saunders; 2008.","DOI":"10.1016\/S0016-5085(08)62021-1"},{"issue":"5","key":"ref39","first-page":"S","article-title":"Utility of a biomarker panel to predict progression to esophageal adenocarcinoma in barrett's esophagus","volume":"146","author":"WA Wolf","year":"2014","journal-title":"Gastroenterology"},{"issue":"2 Pt 1","key":"ref40","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1158\/1078-0432.CCR-06-1385","article-title":"Cyclin A immunocytology as a risk stratification tool for Barrett's esophagus surveillance","volume":"13","author":"P Lao-Sirieix","year":"2007","journal-title":"Clinical cancer research: an official journal of the American Association for Cancer Research"},{"issue":"7","key":"ref41","first-page":"2560","article-title":"Surface expression of minichromosome maintenance proteins provides a novel method for detecting patients at risk for developing adenocarcinoma in Barrett's esophagus","volume":"9","author":"PS Sirieix","year":"2003","journal-title":"Clinical cancer research: an official journal of the American Association for Cancer Research"},{"issue":"5","key":"ref42","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/his.12216","article-title":"Value of alpha-methylacyl-CoA racemase immunochemistry for predicting neoplastic progression in Barrett's oesophagus","volume":"63","author":"F Kastelein","year":"2013","journal-title":"Histopathology"},{"key":"ref43","article-title":"SOX2 as a Novel Marker to Predict Neoplastic Progression in Barrett's Esophagus","author":"S van Olphen","year":"2015","journal-title":"The American journal of gastroenterology"},{"key":"ref44","unstructured":"Rossi E, Grisanti S Fau\u2014Villanacci V, Villanacci V Fau\u2014Della Casa D, Della Casa D Fau\u2014Cengia P, Cengia P Fau\u2014Missale G, Missale G Fau\u2014Minelli L, et al. HER-2 overexpression\/amplification in Barrett's oesophagus predicts early transition from dysplasia to adenocarcinoma: a clinico-pathologic study. (1582\u20134934 (Electronic))."},{"key":"ref45","unstructured":"Cappello F, Rappa F Fau\u2014Anzalone R, Anzalone R Fau\u2014La Rocca G, La Rocca G Fau\u2014Zummo G, Zummo G. CD1a expression by Barrett's metaplasia of gastric type may help to predict its evolution towards cancer. (0007\u20130920 (Print))."},{"issue":"2","key":"ref46","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/jcp.20748","article-title":"hERG1 channels in human esophagus: evidence for their aberrant expression in the malignant progression of Barrett's esophagus","volume":"209","author":"E Lastraioli","year":"2006","journal-title":"J Cell Physiol"},{"issue":"4","key":"ref47","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1093\/gastro\/gov045","article-title":"Expression of p53 predicts risk of prevalent and incident advanced neoplasia in patients with Barrett's esophagus and epithelial changes indefinite for dysplasia","volume":"4","author":"B Horvath","year":"2016","journal-title":"Gastroenterol Rep (Oxf)"},{"issue":"37","key":"ref48","doi-asserted-by":"crossref","first-page":"59535","DOI":"10.18632\/oncotarget.11149","article-title":"hERG1 behaves as biomarker of progression to adenocarcinoma in Barrett's esophagus and can be exploited for a novel endoscopic surveillance","volume":"7","author":"E Lastraioli","year":"2016","journal-title":"Oncotarget"},{"issue":"47","key":"ref49","doi-asserted-by":"crossref","first-page":"e5402","DOI":"10.1097\/MD.0000000000005402","article-title":"Value of cyclin A immunohistochemistry for cancer risk stratification in Barrett esophagus surveillance: A multicenter case-control study","volume":"95","author":"SH van Olphen","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"7414","key":"ref50","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"JP Higgins","year":"2003","journal-title":"Bmj"},{"issue":"3","key":"ref51","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1053\/j.gastro.2011.01.031","article-title":"American gastroenterological association technical review on the management of Barrett's esophagus","volume":"140","author":"SJ Spechler","year":"2011","journal-title":"Gastroenterology"},{"issue":"5","key":"ref52","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/bjs.10484","article-title":"Meta-analysis of biomarkers predicting risk of malignant progression in Barrett's oesophagus","volume":"104","author":"K Altaf","year":"2017","journal-title":"The British journal of surgery"},{"key":"ref53","article-title":"Comment on: 'Meta-analysis of biomarkers predicting risk of malignant progression in Barrett\u2019s oesophagus\u2019 (Br J Surg 2017; 104: 493\u2013502)","author":"VT Janmaat","year":"2017","journal-title":"British Journal of Surgery"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0186305","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T23:20:53Z","timestamp":1719530453000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0186305"}},"subtitle":[],"editor":[{"given":"John","family":"Green","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,10,23]]},"references-count":53,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2017,10,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0186305","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,23]]}}}